StockNews.com assumed coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the medical research company’s stock. Other equities research analysts have also issued research reports about the stock. Maxim Group lowered shares of Biocept from a buy rating […]
Biocept, Inc. (NASDAQ:BIOC – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 160,000 shares, a growth of 15.1% from the March 15th total of 139,000 shares. Based on an average trading volume of 109,200 shares, the short-interest ratio is presently […]
StockNews.com initiated coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the medical research company’s stock. BIOC has been the topic of several other research reports. Maxim Group cut shares of Biocept from a buy rating to a hold rating […]
Maxim Group lowered shares of Biocept (NASDAQ:BIOC – Get Rating) from a buy rating to a hold rating in a research report report published on Friday morning, The Fly reports. Several other brokerages also recently commented on BIOC. Brookline Capital Management downgraded shares of Biocept from a buy rating to a hold rating in a […]
Maxim Group lowered shares of Biocept (NASDAQ:BIOC – Get Rating) from a buy rating to a hold rating in a research report released on Friday, The Fly reports. BIOC has been the topic of a number of other research reports. Brookline Capital Management downgraded shares of Biocept from a buy rating to a hold rating […]